Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon
Technology
E-050-2014
Patent ID
E-050-2014-0-BR-08
Country
BR
Application Type
National Stage
Patent Status
Abandoned
Patent Number
Publication Number
BR112016013804-0
Application Number
BR112016013804-0
IC
NCI
Date Filed
Date Issued
Patent PDF